Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter

The American Journal of Cardiology

Volumn 68, Issue 4, 1991, Pages 335-341

  Crijns, Harry J ^a,b   Van Gelder, Isabelle C ^a,b   Van Gilst, Wiek H ^a,b   Hillege, Hans ^a,b   Gosselink, A Marcel ^c   Lie, Kong I ^a,b  

^a Departments of Cardiology   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; FLECAINIDE; FLECAINIDE ACETATE; QUINIDINE; QUINIDINE ACID SULFATE; QUINIDINE SULFATE; SOTALOL; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOVERSION; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACTUARIAL ANALYSIS; AGED; AMIODARONE; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; ELECTRIC COUNTERSHOCK; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; HEART RATE; HUMAN; MALE; MIDDLE AGE; PROGNOSIS; PROSPECTIVE STUDIES; QUINIDINE; RECURRENCE; SOTALOL;

EID: 0025821048     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(91)90828-9     Document Type: Article

References (33)

1. Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study
2. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter A multicenter study from Stockholm
3. Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrial fibrillation. A controlled clinical trial
4. Verapamil and quinidine in maintaining sinus rhythm after electroconversion of atrial fibrillation
5. Disopyramide in the maintenance of sinus rhythm after electrocardioversion of atrial fibrillation. A placebo controlled one-year follow-up study
6. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials
7. Effects of flecainide and quinidine on human atrial action potentials; role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues
8. Chronic atrial fibrillation Long-term results of direct current conversion
9. Therapy of refractory atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs
10. Effects of flecainide on the atrial defibrillation threshold
11. Successful treatment of atrial tachycardias with flecainide acetate
12. Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythm
13. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment
14. Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugs
15. The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation
16. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation
17. Predicting the spread of cancer: logistic regression analysis
18. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation
19. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias
20. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy
21. Amiodarone for refractory atrial fibrillation
22. Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated atrium
23. Amiodarone in the management of refractory atrial fibrillation
24. Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias
25. Quinidine syncope: paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias
26. Prodromal ventricular premature beats preceded by a diastolic wave
27. Extreme tachycardia complicating the use of disopyramide in atrial flutter
28. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation
29. Incidence and clinical features of the quinidine-associated long QT syndrome implications for patient care
30. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
31. The clinical results of amiodarone in cardiac arrhythmias: optimal dosing
32. Safety and efficacy of amiodarone. The low-dose perspective
33. Long term efficacy and toxicity of high- and low-dose amiodarone regimens